Intervention

Placebo Supplement

ClinicalTrials.gov intervention label

Clinical trials6

Recruiting2

Common conditions8

Lead sponsors shown6

Clinical trials

6 shown

Microbiota Mediated Flavonoid Metabolites for Cognitive HealthNCT07226674 · 2025-11-25

Polyphenols and Cognitive DeclineNCT06507254 · 2025-01-09

Psychobiotics and Mental Health in Obese Women on a Weight-Loss DietNCT06861049 · 2025-02-13

Probiotics and the Gut Brain Axis- Do Probiotics Interact With the Vagal Nerve?NCT04772664 · 2021-08-16

Effects of ISOThrive on Bodyweight, Body Composition, Hunger/Satiety and Cardiac Risk Measures in Overweight AdultsNCT02501356 · 2015-04-01

L-Arginine, Vascular Response and MechanismsNCT01482247 · 2012-04-01

Common conditions

Cognitive Decline2 Cognitive Dysfunction2 Obesity2 Depressive Disorder, Major1 Diabetes1 Hypertension1 Mental Health1 Probiotic1

Leading sponsors

Brigham and Women's Hospital1 Griffin Hospital1 Medical University of Graz1 Medipol University1 University of California, Los Angeles1 University of Ulster1

Trial status mix

COMPLETED4

RECRUITING2

Phase mix

NA5

PHASE21

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.